RUBELLA VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES - IDENTIFICATION OF THE CAPSID AS A TARGET OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED LYSIS AND DEFINITION OF 2 EPITOPES

被引:27
作者
LOVETT, AE
HAHN, CS
RICE, CM
FREY, TK
WOLINSKY, JS
机构
[1] UNIV TEXAS,HLTH SCI CTR,DEPT NEUROL,HOUSTON,TX 77030
[2] WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110
[3] GEORGIA STATE UNIV,DEPT BIOL,ATLANTA,GA 30303
关键词
D O I
10.1128/JVI.67.10.5849-5858.1993
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The role of major histocompatibility complex (MHC) class I-restricted CD8+ cytotoxic T lymphocytes in immunity to rubella virus (RV) infection is unknown. Lymphocytes of RV-immune individuals were prestimulated on an RV-infected MHC class I-matched (or partially matched) fibroblast monolayer which generated CD8+ lymphoblasts capable of lysing RV-infected fibroblast targets in a class I-restricted manner. Using an infectious Sindbis virus (SV) vector which expressed the RV capsid protein (SV/RubC), lymphocytes from 17 of 22 RV-immune individuals prestimulated on RV-infected fibroblast monolayers lysed SV/RubC-infected fibroblast targets. A sequence within the amino terminus of the capsid protein that was previously shown to contain immunodominant class II-restricted T-cell epitopes was evaluated for class I-restricted epitopes. Fibroblast targets pulsed with synthetic peptides representing subsequences within C1 to C29 (subscripts indicate amino acid positions) were lysed effectively when the targets and effectors matched at multiple class I alleles. By limiting the number of matching class I alleles, an A2-restricted epitope was identified within C-9 to C22 and an epitope that could be presented by multiple class I molecules was identified within C-11 to C29. A sequence such as C1 to C29 which contains both MHC class I- and MHC class II-restricted epitopes recognized by a heterologous human population may serve as a component of an effective synthetic vaccine.
引用
收藏
页码:5849 / 5858
页数:10
相关论文
共 46 条
  • [1] AHMED R, 1984, J EXP MED, V60, P521
  • [2] RECOMBINANT VACCINIA VIRUS PRIMES AND STIMULATES INFLUENZA HEMAGGLUTININ-SPECIFIC CYTO-TOXIC T-CELLS
    BENNINK, JR
    YEWDELL, JW
    SMITH, GL
    MOLLER, C
    MOSS, B
    [J]. NATURE, 1984, 311 (5986) : 578 - 579
  • [3] BJORKMAN PJ, 1990, ANN REV BIOCH, V59, P2536
  • [4] BUIMOVICIKLEIN E, 1985, REV INFECT DIS, V7, pS123
  • [5] BUIMOVICIKLEIN E, 1979, PEDIATRICS, V64, P620
  • [6] STUDY OF LYMPHOCYTE INVITRO RESPONSE TO RUBELLA ANTIGEN AND PHYTOHEMAGGLUTININ BY A WHOLE-BLOOD METHOD
    BUIMOVICIKLEIN, E
    VESIKARI, T
    SANTANGELO, CF
    COOPER, LZ
    [J]. ARCHIVES OF VIROLOGY, 1976, 52 (04) : 323 - 331
  • [7] PERSISTENT RUBELLA-VIRUS INFECTION ASSOCIATED WITH CHRONIC ARTHRITIS IN CHILDREN
    CHANTLER, JK
    TINGLE, AJ
    PETTY, RE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (18) : 1117 - 1123
  • [8] CHANTLER JK, 1982, LANCET, V1, P1323
  • [9] RUBELLA-ASSOCIATED ARTHRITIS - RESCUE OF RUBELLA-VIRUS FROM PERIPHERAL-BLOOD LYMPHOCYTES 2 YEARS POSTVACCINATION
    CHANTLER, JK
    FORD, DK
    TINGLE, AJ
    [J]. INFECTION AND IMMUNITY, 1981, 32 (03) : 1274 - 1280
  • [10] LOCALIZATION OF THE VIRUS NEUTRALIZING AND HEMAGGLUTININ EPITOPES OF E1 GLYCOPROTEIN OF RUBELLA-VIRUS
    CHAYE, H
    CHONG, P
    TRIPET, B
    BRUSH, B
    GILLAM, S
    [J]. VIROLOGY, 1992, 189 (02) : 483 - 492